Zydus Lifesciences Limited (ZYDUSLIFE) — Buyback / Redemption | 11 April 2025

· NSE 🟡 Notable Neutral
By StockFin Research Team AI-Assisted Analysis Source: BSE/NSE Filings

Zydus Lifesciences announced incorporation of Zydus MedTech (France) SAS to acquire Amplitude Surgical, completing the first step of its €256.8 million Block Acquisition. The new French subsidiary will hold 100% of the target entity, enabling a future squeeze-out and delisting. This move advances the company's expansion into medical technology while maintaining full ownership control.

📄 View Original Announcement (PDF)

About Zydus Lifesciences Limited (ZYDUSLIFE)

Healthcare · Pharmaceuticals & Biotechnology · Listed on NSE

Market Cap: ₹1,01,800.69 Cr P/E: 22.5

View full ZYDUSLIFE stock details →

📡 Get AI alerts when ZYDUSLIFE files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track ZYDUSLIFE — Free

📊 More ZYDUSLIFE filings

See all ZYDUSLIFE filings →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts when ZYDUSLIFE files new disclosures

Track ZYDUSLIFE filings, board meetings, and corporate actions. Free email alerts at 5 PM.

Track ZYDUSLIFE — Free

Free account · 2 AI queries/day